Skybiotech Healthcare Limited (BOM:512036)
India
· Delayed Price · Currency is INR 138.90
0.00 (0.00%)
At close: Apr 17, 2026
Skybiotech Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 62.86 | 70.52 | - | - | - | - | Upgrade
|
| Other Revenue | -0.3 | 3.84 | 20.02 | 0.54 | 0.23 | 0.2 | Upgrade
|
| Revenue | 62.56 | 74.36 | 20.02 | 0.54 | 0.23 | 0.2 | Upgrade
|
| Revenue Growth (YoY) | -13.15% | 271.34% | 3597.53% | 138.36% | 16.26% | -59.55% | Upgrade
|
| Cost of Revenue | 35.25 | 37.73 | - | - | - | - | Upgrade
|
| Gross Profit | 27.31 | 36.62 | 20.02 | 0.54 | 0.23 | 0.2 | Upgrade
|
| Selling, General & Admin | 17.45 | 19.63 | 0.19 | 0.12 | 0.16 | 0.16 | Upgrade
|
| Other Operating Expenses | 26.94 | 35.7 | 1.08 | 0.48 | 0.43 | 0.49 | Upgrade
|
| Operating Expenses | 49.43 | 60.75 | 1.27 | 0.62 | 0.61 | 0.68 | Upgrade
|
| Operating Income | -22.11 | -24.12 | 18.75 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Interest Expense | - | -0.12 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | -0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -19.97 | -24.26 | 18.75 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Pretax Income | -19.97 | -24.26 | 18.75 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Income Tax Expense | -1.02 | -0.57 | 3.4 | -0 | 0 | -0 | Upgrade
|
| Net Income | -18.95 | -23.69 | 15.35 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Net Income to Common | -18.95 | -23.69 | 15.35 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Shares Outstanding (Basic) | - | 2 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | - | 2 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | - | 0.00% | 84.14% | - | - | - | Upgrade
|
| EPS (Basic) | - | -12.37 | 8.02 | -0.07 | -0.36 | -0.46 | Upgrade
|
| EPS (Diluted) | - | -12.37 | 8.02 | -0.07 | -0.36 | -0.46 | Upgrade
|
| Free Cash Flow | - | -13.68 | -13.37 | -3.73 | 6.1 | 12.8 | Upgrade
|
| Free Cash Flow Per Share | - | -7.14 | -6.98 | -3.59 | 5.86 | 12.31 | Upgrade
|
| Gross Margin | 43.66% | 49.25% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -35.35% | -32.44% | 93.64% | -13.62% | -166.50% | -246.70% | Upgrade
|
| Profit Margin | -30.30% | -31.86% | 76.68% | -13.37% | -166.58% | -246.26% | Upgrade
|
| Free Cash Flow Margin | - | -18.40% | -66.76% | -688.68% | 2683.86% | 6550.84% | Upgrade
|
| EBITDA | -12.64 | -18.71 | 18.76 | -0.06 | -0.36 | -0.46 | Upgrade
|
| EBITDA Margin | -20.21% | -25.16% | 93.68% | -10.83% | -156.29% | -234.15% | Upgrade
|
| D&A For EBITDA | 9.47 | 5.42 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| EBIT | -22.11 | -24.12 | 18.75 | -0.07 | -0.38 | -0.48 | Upgrade
|
| EBIT Margin | -35.35% | -32.44% | 93.64% | -13.62% | -166.50% | -246.69% | Upgrade
|
| Effective Tax Rate | - | - | 18.12% | - | - | - | Upgrade
|
| Revenue as Reported | 62.55 | 74.35 | 20.02 | 0.54 | 0.23 | 0.21 | Upgrade
|
| Advertising Expenses | - | - | 0.04 | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.